Key statistics
As of last trade, Traws Pharma Inc (TRAW:NAQ) traded at 6.79, 13.07% above the 52 week low of 6.01 set on Sep 18, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 6.99 |
---|---|
High | 7.50 |
Low | 6.43 |
Bid | 6.70 |
Offer | 7.21 |
Previous close | 7.11 |
Average volume | 10.07k |
---|---|
Shares outstanding | 25.31m |
Free float | 21.61m |
P/E (TTM) | -- |
Market cap | 7.19m USD |
EPS (TTM) | -5.53 USD |
Data delayed at least 15 minutes, as of Sep 23 2024 15:16 BST.
More ▼
- Traws Pharma, Inc. Appoints Luba Greenwood to Board of Directors
- Traws Pharma, Inc. Announces Special Shareholders Meeting Results
- Traws Pharma Reports Q2 2024 Financial Results, Provides Recent Business Highlights
- Traws Pharma to Host Corporate Update Call on August 15, 2024, at 8:00 AM ET
- Traws Pharma’s ICAR Poster Highlights Potency of COVID-19 Candidate
- Traws Pharma Reports First Quarter 2024 Financial Results and Provides Business Update
- Traws Pharma Completes First Cohort Dosed in Phase 1 Trial for COVID Therapy
- Traws Pharma Announces New Employee Inducement Grants
- Onconova Therapeutics, Inc. and Trawsfynydd Therapeutics, Inc. Announce Business Combination to Form Traws Pharma, Inc, a Best-in-Class Virology and Oncology Company
- Onconova Therapeutics’ Rigosertib Poster Selected for AACR 2024
More ▼